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Abstract
Diabetic nephropathy (DN) is a chronic microangiopathic complication of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). The 
TCF7L2 gene has been reported to be associated with type 2 diabetes risk. We aimed to investigate the impact of TCF7L2 gene on the 
susceptibility of T2DM and DN in a south Indian population. Plus to evaluate the association of rs7903146 in the TCF7L2 gene with T2DM 
in the Indian population. The subjects recruited for this included 55 diabetic cases with diabetic nephropathy, 68 diabetic cases without 
nephropathy, and 82 non-diabetic healthy controls. Genomic DNA was isolated from blood and genotyping of TCF7L2 rs7903146 was 
performed by PCR-RFLP analysis. A literature survey was carried out into the effect of rs7903146 on genetic susceptibility to T2DM in 
Indian populations and we then performed a meta-analysis in order to evaluate its association with T2DM. Analysis of TCF7L2 rs7903146 
in normal controls and diabetics with or without nephropathy demonstrated that the ‘T’ allele is associated with both diabetes (p = 0.049) 
and DN (p = 0.024), but this association is not independent of T2DM. Meta-analysis showed that the mutant allele and genotypes are as-
sociated with T2DM in Indian populations. In summary, a significant association exists between the ‘T’ allele and DN, but this association 
is not independent of T2DM. Pooled meta-analysis of studies on rs7903146 and T2DM confirmed that rs7903146 is significantly associated 
with susceptibility to T2DM in Indian populations. (Endokrynol Pol 2014; 65 (4): 298–305)
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Streszczenie
Nefropatia cukrzycowa (DN, diabetic nephropathy) jest przewlekłym powikłaniem o charakterze mikroangiopatii występującym zarówno 
w cukrzycy typu 1 (T1DM, type 1 diabetes mellitus), jak i typu 2 (T2DM, type 2 diabetes mellitus). Gen TCF7L2 jest związany z ryzykiem cukrzycy 
typu 2. Badanie przeprowadzono w celu dokonania oceny wpływu genu TCF7L2 na podatność na zachorowanie na T2DM i DN w populacji 
Indii Południowych oraz oceny związku między występowaniem polimorfizmu rs7903146 genu TCF7L2 i T2DM w populacji południowej części 
Indii. Do badania włączono 55 przypadków chorych na cukrzycę z nefropatią cukrzycową, 68 przypadków cukrzycy bez nefropatii i 82 osoby 
niechorujące na cukrzycę jako grupę kontrolną. Genomowe DNA izolowano z krwi i przeprowadzono genotypowanie polimorfizmu rs7903146 
genu TCF7L2 metodą analizy PCR-RFLP. Przeprowadzono również przegląd literatury pod kątem danych dotyczących wpływu występowania 
polimorfizmu rs7903146 na genetyczną podatność na T2DM w populacji hinduskiej, a następnie przeprowadzono metaanalizę w celu oceny jego 
związku z T2DM. Analiza polimorfizmu rs7903146 genu TCF7L2 u zdrowych osób z grupy kontrolnej oraz u chorych na cukrzycę z nefropatią 
i bez nefropatii wykazała, że allel T jest związany zarówno z cukrzycą (p = 0,049), jak i DN (p = 0,024), jednak ten związek nie jest niezależny 
od T2DM. Metaanaliza wykazała, że zmutowane allele i genotypy są związane z T2DM w populacji hinduskiej.
Podsumowując, istnieje istotny związek między allelem T i DN, jednak związek ten nie jest niezależny od T2DM. Metaanaliza danych 
z badań dotyczących polimorfizmu rs7903146 i T2DM potwierdziła, że obecność polimorfizmu rs7903146 jest istotnie związana z podat-
nością na zachorowanie na T2DM w populacji hinduskiej. (Endokrynol Pol 2014; 65 (4): 298–305)
Słowa kluczowe: gen TCF7L2; SNP; nefropatia cukrzycowa
Introduction
Diabetic nephropathy (DN) is a chronic microangio-
pathic complication of both type 1 (T1DM) and type 2 
diabetes mellitus (T2DM) and is the primary cause of 
end stage renal disease (ESRD) [1]. Diabetes is character-
ised by hyperglycaemia resulting from the impairment 
of insulin secretion, insulin sensitivity, or both. Type 2 
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diabetes is the most common form of diabetes, affecting 
90% of all people with diabetes. The prevalence of type 2 
diabetes continues to rise, with an increasing number of 
patients at risk of serious diabetes-related microvascular 
and macrovascular complications [2]. Both longitudinal 
and cross-sectional studies have demonstrated that type 
2 diabetes is influenced by several behavioural as well as 
lifestyle factors [3]. Multiple lines of evidence indicate 
that type 2 diabetes is a highly inherited trait and dif-
ferent approaches such as candidate gene and linkage 
studies have been made to identify type 2 diabetes 
genes [4-6]. Genome wide association studies (GWAS) 
have paved the way for researchers to identify more 
genes that have a relatively low effect on type 2 diabetes 
susceptibility [7, 8].
Transcription factor 7-like 2 is the key transcrip-
tional factor regulating glucose metabolism through 
the Wnt signalling pathway. Wnt signalling has also 
been reported to be critical for the development of the 
pancreas and islets during embryonic growth. Fur-
thermore, regulation of Wnt signalling’s timing and 
stimulus is crucial for the development of the pancreas 
[9]. The gene TCF7L2 located on chromosome 10q25.3 
which encodes the transcription factor-4 (TCF-4) has 
been identified as a major T2DM susceptibility gene. 
TCF7L2 rs7903146 SNP is associated with type 2 diabetes 
and may operate via impaired glucagon-like peptide 1 
(GLP1) secretion, which is stimulated more by fat than 
by carbohydrate ingestion. Moreover, the association 
between TCF7L2 variants and T2DM is supported by 
several prospective mechanisms such as decreased 
β-cell mass, liver insulin resistance and altered chroma-
tin state in ‘T’ allele carriers [10, 11]. However, causative 
links between polymorphisms in or near the TCF7L2 
gene and overt type 2 diabetes are uncertain, because 
of the fact that the polymorphisms have not yet been 
proven to correlate with the risk for type 2 diabetes in 
prospective follow-up studies. 
Thus, the objective of this study was to investigate 
the association of the TCF7L2 SNPs with SNP rs7903146 
with well characterised DN. In particular, we investi-
gated whether the association between TCF7L2 poly-
morphisms and DN is independent or dependent of 
diabetes. Further, we analysed the studies conducted 
so far on TCF7L2 gene rs7903146 in diverse populations 
of India, using meta-analysis to assess the possible 
heterogeneity in the allele frequency and the nature as 
well as the magnitude of its association with T2DM.
Material and methods
Subjects and methods
One hundred and twenty three unrelated individuals 
visiting outpatient clinics at Sri Ramachandra Uni-
versity Hospital, Chennai were diagnosed as type 2 
diabetes according to the World Health Organisation 
criteria [12]. All participants underwent detailed clinical 
evaluation followed by biochemical investigations such 
as serum creatinine, fasting and postprandial blood 
glucose and 24-h urinary albumin excretion. Among 
them, 55 patients had overt nephropathy, as indicated 
by persistent urine albuminuria ( > 300 mg/L) in two 
consecutive measurements. Sixty eight individuals 
with normoalbuminuria indicated by urinary albumin 
excretion rate of < 20 µg/min even after ten years 
of diabetes were considered as controls. Eighty two 
age- and sex-matched healthy subjects were selected 
as controls. Individuals with hypertension, congestive 
heart defects and chronic renal disease were excluded 
from the study. This study was approved by the institu-
tional ethics committee of Sri Ramachandra University. 
Informed written consent was obtained from all the 
study participants prior to the commencement of the 
study. Three ml of blood sample was collected from 
each participant, genomic DNA was isolated from 
lymphocytes by standard techniques, and we used 
a published protocol to genotype the TCF7L2 rs7903146 
SNP [13]. Briefly, the rs7903146 was genotyped by am-
plifying 188 bp intron region of TCF7L2 gene by using 
forward primer 5′ ACA ATT AGA GAG CTA AGC ACT 
TTT TAG GTA 3′ and reverse primer 5′ GTG AAG TGC 
CCA AGC TTC TC 3′ followed by the digestion of PCR 
product with RsaI enzyme. The rs7903146 ‘T’ allele was 
characterised by the presence of a 188 bp fragment, 
which was digested further to 159 and 29 bp fragments 
in rs7903146 ‘C’ allele carriers.
A comprehensive search of the electronic databases: 
PubMed, Embase, and ISI Web of Science was done 
using the terms: ‘transcription factor 7-like 2/TCF7L2’, 
‘rs7903146’ and ‘type 2 diabetes mellitus/T2D/T2DM’. 
Papers pertaining to Indian populations with sufficient 
data retrieved up to April 2013 were considered for esti-
mating an odds ratio (OR) and 95% confidence interval 
(CI) in the meta-analysis. All the studies included in the 
meta-analysis are listed in Table I. The data collected 
from the eligible studies included the study reference, 
total number of cases and controls, and numbers of 
genotypes in both cases and controls. 
Statistical analysis
TCF7L2 rs7903146 allele frequencies of the present study 
and ten eligible case control studies were determined by 
direct gene counting. The genotype distribution of this 
SNP in all studies was evaluated for Hardy-Weinberg 
equilibrium by using a HWSIM  program  [14]. The 
strength of the association between TCF7L2 variant 
alleles and their interaction in causing diabetic ne-
phropathy and T2DM was calculated using chi square 
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analysis. The OR and corresponding 95% CI limits were 
also calculated. For TCF7L2 rs7903146, the meta-analysis 
examined the association between the carriers of the 
rare T allele and T2DM risk compared to that for CC 
genotype (CC vs. TC+TT). The pooled OR estimate of 
each study was calculated by the fixed-effects model 
[15]. The odds ratio and confidence interval was graphi-
cally presented as a forest plot. An estimate of potential 
publication bias was carried out by the funnel plot. 
Funnel plot asymmetry was assessed by the method of 
Egger’s linear regression test [16]. The data was ana-
lysed using comprehensive meta-analysis software. For 
a worldwide comparison in a wider context, we have 
also extracted 20kb up and downstream SNPs around 
rs7903146 from the HapMap data (The International 
HapMap Consortium) [17]. 
Results
Association study
The distribution of TCF7L2 rs7903146 genotypes among 
DN, diabetic control and normal controls is documented 
in Table II. The genotype frequency distribution in all three 
groups followed Hardy Weinberg equilibrium (Table II). 
The frequency of ‘T’ allele was 31.9%, 36.8% and 26.2% in 
diabetic nephropathy, diabetic control, and normal control 
respectively. The results of association between different 
groups are also documented in Table II. The frequency 
of TT genotype was slightly higher in DN cases than the 
controls and increased the risk of nephropathy (p = 0.021, 
OR 4.30, 95% CI 1.00–21.44). The ‘T’ allele is associated 
with both diabetes (p = 0.049, OR 1.64, 95% CI 0.97–2.76) 
and diabetic nephropathy (p = 0.024, OR 1.81, 95% CI 
1.04–3.13). The distribution of both allele and genotypes 
did not show significant differences between diabetes and 
diabetic nephropathy (Table II).
Meta-analysis
Meta-analysis of 11 studies showed that the mutant allele 
is associated with T2DM in both fixed effect (P < 0.001, 
OR = 1.336, 95% CI = 1.255–1.422) and random effect 
(P = 0.004, OR = 1.254, 95% CI = 1.075-1.463) (Fig. 2). 
Similar to the allelic meta-analysis, the pooled odds 
ratio for mutant genotypes (dominant model) showed 
a statistically significant association with T2DM adopt-
ing both fixed effect (P < 0.001, OR = 1.451, 95% 
Table I. Main characteristics of the studies included in the meta-analysis
Tabela I. Charakterystyka badań włączonych do metaanalizy
Study reference Total samples Control Case
CC TC TT CC TC TT
Humphries et al., 2006 [43] 1,137 163 111 26 366 375 96
Chandak et al., 2007 [32] 1,354 205 160 34 391 423 141
Bodhini et al., 2007 [35] 2,069 555 391 92 462 455 114
Mahurkar et al., 2008 (Dravidian) [44] 592 130 104 25 175 126 32
Mahurkar et al., 2008 (Indo-European) [44] 547 207 160 35 78 53 14
Sanghera et al., 2008 [34] 1,081 236 224 77 191 261 92
Rees et al., 2008 [45] 1,260 222 166 44 352 360 116
Gupta et al., 2010 [46] 356 62 78 21 55 96 44
Mukhopadhyaya et al., 2010 [47] 80 5 19 16 17 21 2
Uma Jyothi et al., 2013 [36] 1,379 393 194 34 344 328 86
Present study 150 43 35 4 25 36 7
Figure 1. Schematic representation of the article selection process
Rycina 1. Schemat przedstawiający proces selekcji artykułów
301
Endokrynologia Polska 2014; 65 (4)
PR
A
C
E 
O
RY
G
IN
A
LN
E
CI = 1.336–1.576) and random effect (P < 0.001, OR = 1.370, 
95% CI = 1.150–1.832) (Fig. 2). The heterogeneity test and 
sensitivity analysis showed a true heterogeneity between 
studies for ‘T’ allele in the allelic model (Pheterogeneity < 0.001, 
χ2 = 35.36, df = 10, I-squared = 74.5%) and dominant model 
(Pheterogeneity = 0.003, χ
2 = 25.43, df = 10, I-squared = 64.6%). 
The comparison of heterogeneity between studies dem-
onstrated that both allelic and dominant model show 
variations in study outcomes between studies.
The funnel plots generated using standard error 
and precision values for both allelic and dominant 
models using both fixed and random effect models are 
depicted in Figure 3. The shape of the funnel plots was 
symmetrical, suggesting that there was no evidence 
for publication bias for rs7903146 polymorphism. The 
other measures used for assessing the publication bias 
in allelic and dominant models showed absence of 
publication bias (Table III). The classic fail-safe ‘N’ value 
Table II. Genotype frequencies and association statistics for the rs7903146 in diabetic nephropathy, T2DM control and normal 
control
Tabela II. Częstość występowania poszczególnych genotypów i powiązane statystyki dotyczące polimorfizmu rs7903146 
u osób z nefropatią cukrzycową, w grupie chorych na T2DM i grupie kontrolnej obejmującej zdrowe osoby
Control Diabetic without  
nephropathy
Diabetic nephropathy p value* p value** p value***
CC 43 (52.44) 25 (36.76) 20 (30.36) Reference
CT 35 (42.63) 36 (52.94) 27 (49.09) 0.097 0.173 0.869
TT 4 (4.88) 7 (10.29) 8 (14.55) 0.092 0.021 0.550
CT+TT 39 (47.51) 14 (63.23) 14 (63.64) 0.226 0.529 0.643
C 121 (73.8) 86 (63.2) 67 (60.9) Reference
T 43 (26.2) 50 (36.8) 43 (39.1) 0.049 0.024 0.708
HWE p-value 0.350 0.253 0.818 – – –
*Control vs. diabetic without nephropathy, **Control vs. diabetic nephropathy, ***Diabetic without nephropathy vs. diabetic nephropathy
Figure 2. Forest plot of the fixed and random-effects meta-analysis of 11 studies of rs7903146 for T2DM (A. dominant model, B. allelic 
model). Point estimates, 95% confidence intervals (CI), and study weights are provided for each study
Rycina 2. Wykres typu forest plot efektów stałych i losowych w metaanalizie 11 badań polimorfizmu rs7903146 u osób z T2DM 
(A. model dominujący, B. model alleliczny). Dla wszystkich badań przedstawiono estymacje punktowe, 95% przedziały ufności i wagi
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of 136 (P < 0.001, Z = 1.96) for allelic model and 130 
(P < 0.001, Z = 1.96) for dominant model, indicated 
that 136 and 130 null studies (for allelic and dominant 
models respectively) would be required to convert the 
combined ‘P’ value as a non-significant P > 0.05. The 
Orwin’s fail-safe ‘N’ value to bring observed Odds 
Ratio of 1.34 to 1.11 is 15 for allelic model, indicating 
a minimum of 15 null studies would be needed to bring 
the effect size to null. Similarly, Orwin’s fail-safe ‘N’ 
value to bring the observed Odds Ratio of 1.45 to 1.11 
is 23 for dominant model, indicating a minimum of 
23 null studies would be needed to bring the effect size 
to null. Furthermore, the Duval and Tweedie’s ‘trim 
and fill’ procedure also failed to show publication bias.
Discussion
Analysis of TCF7L2 rs7903146 in normal controls and 
diabetics with or without nephropathy demonstrated 
that the ‘T’ allele is associated with both diabetes and 
DN, but this association is not independent of T2DM. 
The meta-analysis conducted using the 11 studies also 
showed a significant association between the mutant 
allele and T2DM in Indian populations. Furthermore, 
comparison on heterogeneity between studies con-
firmed that both the allelic and dominant models 
exhibited heterogeneity. No evidence or publication 
bias was observed. Although the role of TCF7L2 in 
the regulation of microvascular complications such as 
DN is not fully known, there have been several stud-
ies reporting the association of this gene with DN [18, 
19]. Another study showed that the TCF7L2 gene was 
associated only with lower estimated glomerular filtra-
tion rate (eGFR) but not with albuminuria, indicating 
a shared genetic risk for T2DM and DN [20]. In contrast 
to this, no influence of this gene in the pathogenesis of 
diabetes-induced microvascular complications such as 
neuropathy, nephropathy and retinopathy has been 
observed [21].
The first report on  a strong genetic association 
between variants of the TCF7L2 gene and risk of type 
2 diabetes was found in Icelandic individuals, a Dan-
ish cohort, and a cohort of the US population [22]. 
The  subsequent genome-wide  association analysis 
on T2DM showed a strong signal for TCF7L2 in the 
Table III. Measures of publication bias in allelic and 
dominant models 
Tabela III. Pomiar stronniczości publikacji w modelach 
allelicznym i dominującym
Publication bias test Allelic  
model
Dominant 
model
Classic fail-safe ‘N’
Observed studies p value P < 0.001 P < 0.001
Observed studies Z value Z = 1.96 Z = 1.96
Number of missing studies to bring p 
> alpha
136 130
Orwin’s fail-safe ‘N’
OR 1.34 1.45
Number of null studies required 15 23
Begg and Mazumdar rank correlation test:
Kendall’ tau –0.145 –0.11
One-tailed 0.267 0.32
Two-tailed 0.533 0.64
Egger’s regression test:
Intercept value –2.99 –2.45
‘t’ value 1.72 1.75
One-tailed 0.059 0.057
Two-tailed 0.119 0. 119
df 9 9
Figure 3. Egger’s funnel plot as a test for publication bias for 
rs7903146 (A. dominant model, B. allelic model). The precision 
of each study (standard error of the log odds ratio [OR]) is plotted 
against each study’s effect estimate (OR)
Rycina 3. Wykres lejkowy Eggera w ocenie stronniczości publikacji 
dotyczących polimorfizmu rs7903146 (A. model dominujący; 
B. model alleliczny). Przedstawiono dokładność poszczególnych 
badań (błąd standardowy logarytmu ilorazu szans w zależności 
od ich oszacowanego efektu (OR)
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Table SI. Genotype, allele frequencies and Hardy-Weinberg 
equilibrium for TCF7L2 rs7903146 in HapMap populations
Tabela SI. Genotypy, częstość występowania alleli i prawo 
Hardy’ego-Weinberga dla polimorfizmu rs7903146 genu 
TCF7L2 w populacji HapMap
C/C C/T T/T T allele HWp
ASW 23 (41.1) 28 (50.0) 5 (8.9) 38 (33.9) 0.339
CEU 62 (54.9) 39 (34.5) 12 (10.6) 63 (27.9) 0.132
CHB 130 (94.9) 7 (5.1) 0 (0.0) 7 (2.6) 0.759
CHD 101 (92.7) 8 (7.3) 0 (0.0) 8 (3.7) 0.691
GIH 52 (51.5) 42 (41.6) 7 (6.9) 56 (27.7) 0.705
JPT 106 (93.8) 6 (5.3) 1 (0.9) 8 (3.5) 0.018
LWK 58 (52.7) 43 (39.1) 9 (8.2) 61 (27.7) 0.796
MEX 32 (55.2) 22 (37.9) 4 (6.9) 30 (25.9) 0.934
MKK 77 (49.4) 63 (40.4) 16 (10.3) 95 (30.4) 0.561
TSI 44 (43.1) 42 (41.2) 16 (15.7) 74 (36.3) 0.269
YRI 76 (51.7) 63 (42.9) 8 (5.4) 79 (26.9) 0.273
French population [23]. This prompted inclusion of 
TCF7L2 gene variants in a large number of association 
studies in various populations world-wide [24–29]. 
Furthermore, a number of meta-analyses supported 
this robust finding [30, 31]. The replication studies 
of TCF7L2 gene variants among Indian populations 
also showed a strong association of TCF7L2 with 
T2DM [32–36].
Investigations on transcriptional regulation by ap-
plying chromatin immunoprecipitation and sequenc-
ing techniques in a colorectal cancer cell line revealed 
overexpression of TCF7L2. This provided the first 
evidence for its central node for T2DM susceptibility 
[37]. Later, several studies using pancreatic cells and 
a rat insulin-producing cell line (Ins-1) have indicated 
a potential role of TCF7L2 in human T2DM [38–40]. 
A recent study demonstrated that the liver-specific 
TCF4 overexpression increases hepatic glucose pro-
duction, indicating TCF7L2 directly activates metabolic 
genes [41]. To date, most studies with TCF7L2 have 
genotyped either the one or two most associated SNPs 
reported in the original study [22], and ignored the 
remaining polymorphisms of the TCF7L2 gene. The 
rs7903146 also showed variations among the world 
populations with the highest ‘T’ allele frequency in 
HapMap  populations of African (YRI, MKK, ASW 
and LWK) and European (CEU and TSI) followed by 
Mexican (MEX) ancestry and south Asian populations 
(GIH). East Asian populations (CHB, CHD and JPT) 
exhibited slightly fewer ‘T’ allele frequencies than the 
rest of the world populations (Table SI). 
Analysis of 20kb up and downstream SNPs around 
rs7903146 from the HapMap data demonstrated that 
the European (CEU and TSI) and Mexican (MEX) 
populations formed a single large LD block. Unlike 
in Caucasians, the African populations exhibited 
weak LD and formed two small LD blocks. In East 
Asian populations (CHB, CHD and JPT) and south 
Asian populations (GIH), the LD is fragmented (Fig. 
S1). Although the functional role of this intronic SNP 
(rs7903146) is still unknown, the variant risk allele is 
associated with impaired insulin secretion, reduction 
of total islet numbers, and quantitative as well as 
qualitative morphological changes in human islets 
[42]. Furthermore, carriers of risk variants at TCF7L2 
are more likely to fail sulfonulyurea therapy than 
metformin and more likely to be on insulin therapy 
rather than diet alone. Thus, the screening of the entire 
gene leads to a complete understanding of the variants 
of exons and the surrounding region with a stronger 
effect on the risk of disease.
In conclusion, we suggest that TCF7L2 is a po-
tent gene in not just causing T2DM, but also DN. 
This study could be extended to a larger number of 
diabetes-induced nephropathic individuals to gain 
more evidence. Thus it may prove to be a strong pre-
dictive classifier to provide an index of ‘at risk’ status, 
including probability estimates to T2DM likelihood 
and nephropathic complications thereafter. These 
studies can further aid in translational research, as 
categorising diabetic individuals based on their ge-
netic makeup will help personalise medication and 
improve treatment options.
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